{{Rsnum
|rsid=2390582
|Chromosome=1
|position=90478350
|Orientation=plus
|GMAF=0.2011
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 71.4 | 26.8 | 1.8
| HCB | 54.2 | 40.5 | 5.3
| JPT | 61.9 | 34.5 | 3.5
| YRI | 84.9 | 14.4 | 0.7
| ASW | 82.5 | 17.5 | 0.0
| CHB | 54.2 | 40.5 | 5.3
| CHD | 46.2 | 48.1 | 5.7
| GIH | 42.0 | 46.0 | 12.0
| LWK | 85.5 | 14.5 | 0.0
| MEX | 43.9 | 50.9 | 5.3
| MKK | 91.7 | 8.3 | 0.0
| TSI | 75.2 | 23.8 | 1.0
| HapMapRevision=28
}}{{GWAS Summary
|SNP=rs2390582
|PubMedID=17903303
|Condition=Coronary artery calcification
|Gene=Intergenic
|Risk Allele=
|pValue=1.00E-006
|OR=NA
|95CI=
|OA=1
}}

{{PharmGKB
|RSID=rs2390582
|Name_s=
|Gene_s=-
|Feature=
|Evidence=PubMed ID:17903303; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: Genome-wide association study for subclinical atherosclerosis in major arterial territories in the NHLBI's Framingham Heart Study (Initial Sample Size: 673-984 individuals, depending on measure (Framingham); Replication Sample Size: NR). This variant is associated with Coronary artery calcification.
|Drugs=
|Drug Classes=
|Diseases=Arteriosclerosis; Cardiovascular Diseases; Coronary Disease
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA162356500
}}

{{PMID Auto
|PMID=17903293
|Title=Genome-wide association with select biomarker traits in the Framingham Heart Study.
|OA=1
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs2390582
|overall_frequency_n=22
|overall_frequency_d=128
|overall_frequency=0.171875
|n_genomes=12
|n_genomes_annotated=0
|n_haplomes=14
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}